IBS-D (DIARRHEA-PREDOMINANT)
Clinical trials for IBS-D (DIARRHEA-PREDOMINANT) explained in plain language.
Never miss a new study
Get alerted when new IBS-D (DIARRHEA-PREDOMINANT) trials appear
Sign up with your email to follow new studies for IBS-D (DIARRHEA-PREDOMINANT), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common probiotic soothe IBS? new trial seeks answers
Symptom relief Recruiting nowThis study tests whether a probiotic called Saccharomyces boulardii can reduce symptoms of irritable bowel syndrome (IBS) in adults. About 406 people with non-constipated IBS will take either the probiotic or a placebo daily for 8 weeks. Researchers will measure changes in sympto…
Matched conditions: IBS-D (DIARRHEA-PREDOMINANT)
Phase: PHASE3 • Sponsor: Biocodex • Aim: Symptom relief
Last updated Jun 17, 2026 04:26 UTC
-
Could a Mucus-Busting supplement boost an IBS Drug's power?
Symptom relief Recruiting nowThis study tests whether adding a dietary supplement called NAC to the standard IBS-D drug rifaximin can better control diarrhea and stomach pain. About 225 adults with IBS-D will receive either the combination or a placebo for several weeks. The goal is to see if NAC helps break…
Matched conditions: IBS-D (DIARRHEA-PREDOMINANT)
Phase: PHASE2 • Sponsor: Mark Pimentel, MD • Aim: Symptom relief
Last updated Jun 17, 2026 04:26 UTC